» Articles » PMID: 8495973

Cytokine-mediated Inactivation of Malarial Gametocytes is Dependent on the Presence of White Blood Cells and Involves Reactive Nitrogen Intermediates

Overview
Journal Immunology
Date 1993 Apr 1
PMID 8495973
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Supernatants of human peripheral blood mononuclear cells (PBMC) incubated for 24 hr in the presence of extracts of freeze-thawed blood stage parasites of Plasmodium vivax or P. falciparum mediate inactivation of gametocytes of either species when incubated in vitro with whole human blood cells. Cultured P. falciparum gametocytes incubated with these malaria extract-stimulated PBMC supernatants in the presence of human blood from which white blood cells (WBC) had been removed were not inactivated. Thus the effects of the PBMC supernatants on gametocyte infectivity were dependent upon the presence of WBC. The suppressive effects mediated in the presence of WBC could be partially reversed in the presence of concentrations of 1 mM or higher of the L-arginine analogue NGL-monomethyl arginine acetate (L-NMMA). Our results indicate that the effects of WBC in inactivating gametocytes are due, at least in part, to a mechanism involving an L-arginine-dependent pathway. Previous studies have shown that the mediators of gametocyte inactivation in the stimulated PBMC supernatants comprised tumour necrosis factor (TNF) acting in conjunction with unidentified, but essential, 'complementary factors'. In the present study we show that these mediators, TNF and complementary factors, affect gametocytes indirectly through their interaction with WBC.

Citing Articles

Immune mechanisms targeting malaria transmission: opportunities for vaccine development.

Bansal G, Kumar N Expert Rev Vaccines. 2024; 23(1):645-654.

PMID: 38888098 PMC: 11472754. DOI: 10.1080/14760584.2024.2369583.


Evaluation of a new fusion antigen, cd loop and HAP2-GCS1 domain (cd-HAP) of Plasmodium falciparum Generative Cell Specific 1 antigen formulated with various adjuvants, as a transmission blocking vaccine.

Pourhashem Z, Nourani L, Sani J, Yousefi H, Pirahmadi S, Sabouri M Malar J. 2023; 22(1):374.

PMID: 38071314 PMC: 10710725. DOI: 10.1186/s12936-023-04798-7.


Transmission efficiency of Plasmodium vivax at low parasitaemia.

Surit T, Sripoorote P, Kumpitak C, Suansomjit C, Maneechai N, Cui L Malar J. 2023; 22(1):22.

PMID: 36658583 PMC: 9854148. DOI: 10.1186/s12936-022-04435-9.


A Novel Drug Assay for Assessing the Transmission-Blocking Activity of Compounds on Field-Isolated Plasmodium falciparum Gametocytes.

Ouologuem D, Dembele L, Dara A, Kone A, Diallo N, Sangare C Antimicrob Agents Chemother. 2022; 66(12):e0100122.

PMID: 36321830 PMC: 9764978. DOI: 10.1128/aac.01001-22.


Infectivity of patent Plasmodium falciparum gametocyte carriers to mosquitoes: establishing capacity to investigate the infectious reservoir of malaria in a low-transmission setting in The Gambia.

Ahmad A, Soumare H, Camara M, Jadama L, Gaye P, Bittaye H Trans R Soc Trop Med Hyg. 2021; 115(12):1462-1467.

PMID: 34107048 PMC: 8643495. DOI: 10.1093/trstmh/trab087.


References
1.
Perlstein R, MOUGEY E, Jackson W, Neta R . Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo. Lymphokine Cytokine Res. 1991; 10(1-2):141-6. View

2.
Walliker D, Quakyi I, Wellems T, McCutchan T, Szarfman A, London W . Genetic analysis of the human malaria parasite Plasmodium falciparum. Science. 1987; 236(4809):1661-6. DOI: 10.1126/science.3299700. View

3.
Liew F, Li Y, Millott S . Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol. 1990; 145(12):4306-10. View

4.
James S . The effector function of nitrogen oxides in host defense against parasites. Exp Parasitol. 1991; 73(2):223-6. DOI: 10.1016/0014-4894(91)90025-r. View

5.
Karunaweera N, Carter R, Grau G, Kwiatkowski D, Del Giudice G, Mendis K . Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clin Exp Immunol. 1992; 88(3):499-505. PMC: 1554505. DOI: 10.1111/j.1365-2249.1992.tb06478.x. View